NasdaqGM - Nasdaq Real Time Price USD
Relay Therapeutics, Inc. (RLAY)
2.9500
-0.2000
(-6.35%)
At close: May 7 at 4:00:01 PM EDT
2.8600
-0.09
(-3.05%)
After hours: May 7 at 7:59:28 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 8 | 7 |
| Avg. Estimate | -0.48 | -0.48 | -1.81 | -1.79 |
| Low Estimate | -0.53 | -0.62 | -2.05 | -2.59 |
| High Estimate | -0.37 | -0.29 | -1.23 | -1.24 |
| Year Ago EPS | -0.69 | -0.63 | -2.36 | -1.81 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 7 | 10 |
| Avg. Estimate | 75k | 62.5k | 14.28M | 17.98M |
| Low Estimate | -- | -- | 7.7M | -- |
| High Estimate | 500k | 500k | 37.7M | 77.21M |
| Year Ago Sales | -- | -- | 10.01M | 14.28M |
| Sales Growth (year/est) | 0.00% | 0.00% | 42.66% | 25.95% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.73 | -0.78 | -0.55 | -0.48 |
| EPS Actual | -0.69 | -0.63 | -0.45 | -0.46 |
| Difference | 0.04 | 0.15 | 0.1 | 0.02 |
| Surprise % | 5.34% | 19.62% | 17.90% | 4.10% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.48 | -0.48 | -1.81 | -1.79 |
| 7 Days Ago | -0.47 | -0.51 | -2.01 | -2.02 |
| 30 Days Ago | -0.49 | -0.53 | -2.1 | -2.19 |
| 60 Days Ago | -0.51 | -0.57 | -2.2 | -2.29 |
| 90 Days Ago | -0.61 | -0.65 | -2.55 | -2.51 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 2 | 2 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RLAY | 30.68% | 24.11% | 23.36% | 0.89% |
| S&P 500 | 12.50% | 3.24% | 7.95% | 13.84% |
Upgrades & Downgrades
| Maintains | Guggenheim: Buy to Buy | 5/7/2025 |
| Initiated | Wells Fargo: Equal-Weight | 4/17/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/7/2025 |
| Maintains | Goldman Sachs: Buy to Buy | 2/27/2025 |
| Maintains | Stifel: Buy to Buy | 2/27/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/14/2025 |
Related Tickers
BPMC Blueprint Medicines Corporation
99.80
+0.65%
KYMR Kymera Therapeutics, Inc.
29.11
+1.89%
ARVN Arvinas, Inc.
6.67
-4.03%
NUVB Nuvation Bio Inc.
2.0400
-2.39%
DAWN Day One Biopharmaceuticals, Inc.
6.30
-9.87%
RVMD Revolution Medicines, Inc.
37.66
+0.59%
NRIX Nurix Therapeutics, Inc.
9.30
-3.58%
VSTM Verastem, Inc.
6.69
+2.45%
SNDX Syndax Pharmaceuticals, Inc.
9.99
-6.11%
IDYA IDEAYA Biosciences, Inc.
17.83
+0.45%